Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

68.36
-1.4100-2.02%
Pre-market: 68.710.3500+0.51%04:00 EST
Volume:3.34M
Turnover:228.77M
Market Cap:12.16B
PE:-57.49
High:69.64
Open:69.06
Low:67.33
Close:69.77
52wk High:104.32
52wk Low:31.36
Shares:177.91M
Float Shares:101.68M
Volume Ratio:0.65
T/O Rate:3.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1891
EPS(LYR):-6.2273
ROE:-72.61%
ROA:-9.08%
PB:23.95
PE(LYR):-10.98

Loading ...

Tempus AI Unveils Eight New GI Cancer Studies at 2026 ASCO Symposium

Reuters
·
Yesterday

Tempus AI COO Ryan Fukushima Reports Disposal of Common Shares

Reuters
·
Yesterday

Tempus AI Director Jennifer Doudna Reports Sale of Common Shares

Reuters
·
Jan 07

Tempus AI Inc. to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 06

Cathie Wood Loads Up On Tempus AI And This George Soros-Backed Company's Stock, Dumps Roku And Shopify Shares

Benzinga_recent_news
·
Jan 06

Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares

Reuters
·
Dec 23, 2025

Form 4 | Tempus AI, Inc.'s CEO Eric Lefkofsky sold 112,552 shares.

Filings Track
·
Dec 23, 2025

Tempus AI Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Dec 22, 2025

Form 144 | Tempus AI's Director and Officer Eric Lefkofsky proposes to sell 166,250 Shares, with a total value of approximately $10.74 Million.

Filings Track
·
Dec 19, 2025

Tempus AI EVP and Chief Admin & Legal Officer Erik Phelps Reports Disposal of Common Shares

Reuters
·
Dec 19, 2025

Tempus AI Is Maintained at Neutral by JP Morgan

Dow Jones
·
Dec 16, 2025

Tempus AI Inc (Pre-Reincorporation) : JP Morgan Cuts Target Price to $80 From $85

THOMSON REUTERS
·
Dec 15, 2025

Tempus AI CFO James William Rogers Reports Sale of Common Shares

Reuters
·
Dec 13, 2025

5 Stocks to Buy and 5 to Sell for 2026

Benzinga_recent_news
·
Dec 12, 2025

Tempus AI Director Frederick Wayne Reports Sale of Common Shares

Reuters
·
Dec 10, 2025

Tempus AI Unveils Ten New Breast Cancer Research Findings at 2025 SABCS

Reuters
·
Dec 09, 2025

Tempus AI COO Ryan Fukushima Reports Disposal of Common Shares

Reuters
·
Dec 04, 2025

Tempus AI Director Jennifer Doudna Reports Sale of Common Shares

Reuters
·
Dec 04, 2025

Tempus AI Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Dec 03, 2025

Morgan Stanley Raises Price Target on Tempus AI to $85 From $80, Keeps Overweight Rating

MT Newswires Live
·
Dec 02, 2025